Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Rampotas A 

PROVIDER: S-EPMC8558790 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature